Casey R. Dorr, Ph.D.

Affiliations: 
2011 Molecular, Cellular, Developmental Biology and Genetics University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Virology Biology, Cell Biology, Biochemistry
Google:
"Casey Dorr"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Louis Mansky grad student 2011 UMN
 (Compounds Derived from Birch Trees that Inhibit HIV-1 Replication.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Reininger KA, Onyeaghala G, Anderson-Haag T, et al. (2022) Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers. Clinical Transplantation. e14893
Al-Kofahi M, Oetting WS, Schladt DP, et al. (2021) Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry. Journal of Clinical Pharmacology
Nguyen TT, Pearson RA, Mohamed ME, et al. (2020) Pharmacogenomics in kidney transplant recipients and potential for integration into practice. Journal of Clinical Pharmacy and Therapeutics
Mohamed ME, Schladt DP, Guan W, et al. (2019) Tacrolimus Troughs and Genetic Determinants of Metabolism in Kidney Transplant Recipients: A comparison of four ancestry groups. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Oetting WS, Wu B, Schladt DP, et al. (2019) Genetic Variants Associated with Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome Wide Association Studies. Transplantation
Oetting WS, Schladt DP, Dorr CR, et al. (2019) Analysis of 75 Candidate SNPs Associated with Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A. Transplantation
Dorr CR, Wu B, Remmel RP, et al. (2018) Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing. The Pharmacogenomics Journal
Seibert SR, Schladt DP, Wu B, et al. (2018) Tacrolimus Trough and Dose Intra-Patient Variability and CYP3A5 Genotype: Effects on Acute Rejection and Graft Failure in European American and African American Kidney Transplant Recipients. Clinical Transplantation. e13424
Scheibner A, Remmel R, Schladt D, et al. (2018) Tacrolimus Elimination in Four Patients with a CYP3A5*3/*3 CYP3A4*22/*22 Genotype. Pharmacotherapy
Oetting WS, Wu B, Schladt DP, et al. (2018) Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients. Pharmacogenomics
See more...